Y M Rustum
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
-
- Cancer therapeutics and mechanisms
- Biochemical and Molecular Research
- DNA Repair Mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 10
- Biochemical and Molecular Research 9
- Oncology 19
- Colorectal Cancer Treatments and Studies 14
- Metal complexes synthesis and properties 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- E. Mayhew (2 shared papers)William R. Greco (3 shared papers)Shu Cao (2 shared papers)A. Harstrick (3 shared papers)U. Vanhoefer (3 shared papers)H. Wilke (2 shared papers)S. Seeber (2 shared papers)Ming Yin (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Biochemical Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Y M Rustum
29 papers receiving 870 citations
Peers
Comparison fields: 5 of 93
- Oncology 509
- Molecular Biology 435
- Cancer Research 95
- Biomaterials 82
- Pathology and Forensic Medicine 78
Countries citing papers authored by Y M Rustum
This map shows the geographic impact of Y M Rustum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y M Rustum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y M Rustum more than expected).
Fields of papers citing papers by Y M Rustum
This network shows the impact of papers produced by Y M Rustum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y M Rustum. The network helps show where Y M Rustum may publish in the future.
Co-authors
The 25 scholars most cited alongside Y M Rustum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 162 | |
| 2 | Modeling of the time-dependency of in vitro drug cytotoxicity and resistance. | 1998 | 89 |
| 3 | Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. | 1976 | 70 |
| 4 | 1987 | 59 | |
| 5 | Attenuation of the antitumor activity of 5-fluorouracil by (R)-5-fluoro-5,6-dihydrouracil. | 1995 | 58 |
| 6 | DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. | 1996 | 51 |
| 7 | Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis. | 1998 | 40 |
| 8 | Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma. | 2000 | 39 |
| 9 | 1995 | 34 | |
| 10 | 1996 | 32 | |
| 11 | 1997 | 28 | |
| 12 | Comparative DNA strand breakage induced by FUra and FdUrd in human ileocecal adenocarcinoma (HCT-8) cells: relevance to cell growth inhibition. | 1991 | 28 |
| 13 | Contrasting patterns of DNA fragmentation induced by thymidylate synthase inhibitors, ZD1694 and AG-331. | 1995 | 25 |
| 14 | Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine. | 1999 | 23 |
| 15 | 1997 | 21 | |
| 16 | Quantitation of dihydrofolate reductase and thymidylate synthase mRNAs in vivo and in vitro by polymerase chain reaction. | 1992 | 19 |
| 17 | Growth of human urological tumors on extracellular matrix as a model for the in vitro cultivation of primary human tumor explants. | 1986 | 18 |
| 18 | Dimerization of mitochondrial Bax is associated with increased drug response in Bax-transfected A253 cells. | 1999 | 16 |
| 19 | 1993 | 15 | |
| 20 | Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine. | 1994 | 14 |
About Y M Rustum
Y M Rustum is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 29 papers that have together received 900 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Cancer therapeutics and mechanisms (10 papers), Biochemical and Molecular Research (9 papers), Gastric Cancer Management and Outcomes (4 papers), Synthesis and Biological Evaluation (3 papers), Metal complexes synthesis and properties (3 papers), Cancer Treatment and Pharmacology (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Oncology (509 citations), Molecular Biology (435 citations), Cancer Research (95 citations), Biomaterials (82 citations) and Pathology and Forensic Medicine (78 citations). Y M Rustum has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include E. Mayhew, William R. Greco, Shu Cao, A. Harstrick, U. Vanhoefer, H. Wilke, S. Seeber, Ming Yin, Shousong Cao and Harry K. Slocum. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer Chemotherapy and Pharmacology, Biochemical Pharmacology, Journal of Pharmacology and Experimental Therapeutics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.